Description

Dynamic single-cell analysisCellChorus is a life science company that applies AI/ML to “watch” and evaluate 1000s of videos of cell-cell interactions so scientists can develop and deliver better cell therapies, antibody therapeutics and vaccines. Our platform allows us to evaluate thousands of mini-microscopy experiments in parallel and quantify movement, contact, killing, survival and other activities of single cells and cell-cell interactions. Our customers include top-25 biopharma companies developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy) across oncology, infectious diseases and auto-immune disorders.

 


ACTIVE FOUNDERS

Founder 1

Dan Meyer,

Daniel Meyer is the CEO of CellChorus, the leader in providing high-throughout dynamic single-cell analysis to the life sciences industry. Dan was the Chief Operating Officer and a board member of Genospace until its acquisition by HCA Healthcare (NYSE:HCA). He was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc. Dan holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.

Twitter: https://twitter.com/_danmeyer | Linkedin: https://www.linkedin.com/in/danmeyer/


Founder 2

Navin Varadarajan,

Twitter: | Linkedin:


Founder 3

,

Twitter: | Linkedin:


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in
Nation
Founded in

2017

Team Size

4

Closed
Open hours today: By appointment only
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 26 September 2022 8:45 local time

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected